SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

8 Oct 2015 07:00

RNS Number : 5861B
Victrex PLC
08 October 2015
 



 

 

 

 

 

 

8 October 2015

 

Victrex plc - Full year pre-close trading update

 

"A good finish to 2015"

 

Victrex plc, an innovative world leader in high performance polymer solutions, today announces its full year pre-close trading update for the financial year ended 30 September 2015, ahead of its preliminary results on 8 December 2015.

 

Victrex delivered a good finish to 2015, with overall performance in line with our expectations, including a robust fourth quarter (Q4). For the year as a whole, the value of our balanced portfolio helped to drive growth and fully overcome headwinds including weaker sales in Oil & Gas, the effects of US Spine market consolidation on our Invibio medical business and the significant impact from foreign currency this year.

 

On a reported basis, full year Group revenue of £263.5m was 4% ahead of the prior year (FY 2014: £252.6m), with Q4 Group revenue of £68.7m being flat on the prior year period. Foreign currency, at a profit level, was a headwind of approximately £8m for the full year, which we will fully overcome.

 

At a volume level, full year Group sales volume of 4,217 tonnes was 19% ahead of the prior year (FY 2014: 3,551 tonnes). Q4 Group sales volume of 1,119 tonnes was 6% ahead of the prior year period (Q4 2014: 1,056 tonnes). Sales volumes reflect our overall momentum in VPS remaining positive during the fourth quarter, with growth across Aerospace, Automotive, General Industrial and strong Consumer Electronics volumes offsetting Oil & Gas, as previously communicated.

 

Invibio performance was in line with our previous guidance, with full year revenue of £50.5m being 5% down compared to the prior year (FY 2014: £53.4m). This reflects the effects of consolidation in the US Spine market.

 

Outlook

Our overall growth momentum remains positive as we start our new financial year. Whilst we are mindful of the continuing weakness in Oil & Gas and the need to improve Invibio performance in 2016, our balanced portfolio keeps us well placed to continue driving growth and creating value, in line with our long term strategy.

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions focused on the Aerospace, Automotive, Electronics, Energy and Medical markets. Every day, millions of people rely on products or applications which contain our polymers, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are delivering leading edge solutions to shape future performance for our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGQWUUPAGAM
Date   Source Headline
18th Jun 20092:57 pmRNSDirector/PDMR Shareholding
18th Jun 20092:37 pmRNSDirector/PDMR Shareholding
3rd Jun 200911:29 amRNSBlocklisting Interim Review
2nd Jun 20093:51 pmRNSHolding(s) in Company
29th May 20091:30 pmRNSTotal Voting Rights
19th May 20094:02 pmRNSDirector/PDMR Shareholding
19th May 20097:00 amRNSHalf Yearly Report
30th Apr 200912:03 pmRNSTotal Voting Rights
17th Apr 20093:13 pmRNSDirector/PDMR Shareholding
15th Apr 200912:05 pmRNSHolding(s) in Company
7th Apr 20097:00 amRNSHalf Year Trading Update
31st Mar 20091:48 pmRNSTotal Voting Rights
30th Mar 200910:46 amRNSHolding(s) in Company
18th Mar 200911:54 amRNSDirector/PDMR Shareholding
4th Mar 20092:18 pmRNSDirector/PDMR Shareholding
2nd Mar 20092:41 pmRNSTotal Voting Rights
18th Feb 20093:41 pmRNSDirector/PDMR Shareholding
17th Feb 20094:45 pmRNSDirector/PDMR Shareholding
11th Feb 200910:41 amRNSResult of AGM
10th Feb 20097:00 amRNSAGM and Interim Management Statement
19th Jan 20092:35 pmRNSDirector/PDMR Shareholding
7th Jan 200911:11 amRNSAnnual Information Update
5th Jan 20093:13 pmRNSAnnual Report and Accounts
5th Jan 20092:07 pmRNSTotal Voting Rights
18th Dec 200812:21 pmRNSDirector/PDMR Shareholding
18th Dec 200810:53 amRNSDirector/PDMR Shareholding
16th Dec 20087:00 amRNSFinal Results
2nd Dec 200810:52 amRNSBlocklisting Interim Review
1st Dec 20083:58 pmRNSHolding(s) in Company
1st Dec 20087:00 amRNSTrading Statement
28th Nov 20082:32 pmRNSTotal Voting Rights
24th Nov 200811:40 amRNSDirector/PDMR Shareholding
21st Nov 20082:47 pmRNSHolding(s) in Company
20th Nov 20084:36 pmRNSHolding(s) in Company
7th Nov 20089:49 amRNSTotal Voting Rights
21st Oct 200812:01 pmRNSDirector/PDMR Shareholding
7th Oct 20087:00 amRNSAnnual Trading Update
30th Sep 20082:57 pmRNSTotal Voting Rights
18th Sep 20083:31 pmRNSDirector/PDMR Shareholding
29th Aug 20081:40 pmRNSTotal Voting Rights
20th Aug 200811:30 amRNSDirector/PDMR Shareholding
31st Jul 20084:15 pmRNSTotal Voting Rights
31st Jul 20087:00 amRNSInterim Management Statement
28th Jul 200812:54 pmRNSBoard Appointments
17th Jul 20083:34 pmRNSDirector/PDMR Shareholding
1st Jul 200810:15 amRNSTotal Voting Rights
20th Jun 20082:27 pmRNSHolding(s) in Company
19th Jun 20082:33 pmRNSDirector/PDMR Shareholding
13th Jun 20081:06 pmRNSDirector/PDMR Shareholding
30th May 200811:01 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.